Biocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pharmaceutical company said on Friday. Biocon said the first set of trials using the drug were done in Mumbai and Delhi.from Industry-Economic Times
Read The Rest:economictimes...
